Pretraga

Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1015449

Growth factors FGF8 and FGF2 and their receptor FGFR1, transcriptional factors MSX-1 and MSX-2 and apoptotic factors p19 and RIP5 participate in the early human limb development

Becic, Tina; Kero, Darko; Vukojevic, Katarina; Mardesic, Snjezana; Saraga-Babic, Mirna
Growth factors FGF8 and FGF2 and their receptor FGFR1, transcriptional factors MSX-1 and MSX-2 and apoptotic factors p19 and RIP5 participate in the early human limb development // Acta Histochemica, 120 (2018), 3; 205-2014 doi:10.1016/j.acthis.2018.01.008 (međunarodna recenzija, članak, znanstveni)

CROSBI ID: 1015449 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Growth factors FGF8 and FGF2 and their receptor FGFR1, transcriptional factors MSX-1 and MSX-2 and apoptotic factors p19 and RIP5 participate in the early human limb development

Autori
Becic, Tina ; Kero, Darko ; Vukojevic, Katarina ; Mardesic, Snjezana ; Saraga-Babic, Mirna

Izvornik
Acta Histochemica (0065-1281) 120 (2018), 3; 205-2014

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
growth factors, transcirptional factors, apoptotic factors, limb development

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA

Ustanove:
Medicinski fakultet, Split

Profili:

Avatar Url Mirna Saraga-Babić (autor)

Avatar Url Katarina Vukojević (autor)

Avatar Url Darko Kero (autor)

Avatar Url Tina Bečić (autor)

Poveznice na cjeloviti tekst rada:

doi

Citiraj ovu publikaciju:

Becic, Tina; Kero, Darko; Vukojevic, Katarina; Mardesic, Snjezana; Saraga-Babic, Mirna
Growth factors FGF8 and FGF2 and their receptor FGFR1, transcriptional factors MSX-1 and MSX-2 and apoptotic factors p19 and RIP5 participate in the early human limb development // Acta Histochemica, 120 (2018), 3; 205-2014 doi:10.1016/j.acthis.2018.01.008 (međunarodna recenzija, članak, znanstveni)
Becic, T., Kero, D., Vukojevic, K., Mardesic, S. & Saraga-Babic, M. (2018) Growth factors FGF8 and FGF2 and their receptor FGFR1, transcriptional factors MSX-1 and MSX-2 and apoptotic factors p19 and RIP5 participate in the early human limb development. Acta Histochemica, 120 (3), 205-2014 doi:10.1016/j.acthis.2018.01.008.
@article{article, author = {Becic, Tina and Kero, Darko and Vukojevic, Katarina and Mardesic, Snjezana and Saraga-Babic, Mirna}, year = {2018}, pages = {205-2014}, DOI = {10.1016/j.acthis.2018.01.008}, keywords = {growth factors, transcirptional factors, apoptotic factors, limb development}, journal = {Acta Histochemica}, doi = {10.1016/j.acthis.2018.01.008}, volume = {120}, number = {3}, issn = {0065-1281}, title = {Growth factors FGF8 and FGF2 and their receptor FGFR1, transcriptional factors MSX-1 and MSX-2 and apoptotic factors p19 and RIP5 participate in the early human limb development}, keyword = {growth factors, transcirptional factors, apoptotic factors, limb development} }
@article{article, author = {Becic, Tina and Kero, Darko and Vukojevic, Katarina and Mardesic, Snjezana and Saraga-Babic, Mirna}, year = {2018}, pages = {205-2014}, DOI = {10.1016/j.acthis.2018.01.008}, keywords = {growth factors, transcirptional factors, apoptotic factors, limb development}, journal = {Acta Histochemica}, doi = {10.1016/j.acthis.2018.01.008}, volume = {120}, number = {3}, issn = {0065-1281}, title = {Growth factors FGF8 and FGF2 and their receptor FGFR1, transcriptional factors MSX-1 and MSX-2 and apoptotic factors p19 and RIP5 participate in the early human limb development}, keyword = {growth factors, transcirptional factors, apoptotic factors, limb development} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE

Citati:

    Altmetrijski pokazatelji:


    Podijeli:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font
    CROSBI koristi kolačiće (cookies) kako bi poboljšao funkcionalnost stranice.